Remedium Capital Partners, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 7, 2026, Remedium Capital Partners, Llc disclosed 4 stock positions valued at approximately $451.63M as of quarter-end June 30, 2026. The largest holdings include Oruka Therapeutics Inc, Spyre Therapeutics Inc, and Apogee Therapeutics Inc.
- Report Period
- June 30, 2026
- No. of Stocks
- 4
- Portfolio Value
- $451.63M
Holdings by Sector
Remedium Capital Partners, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics Inc | ORKA | Other | 32.99% | 1,565,661 | -323,454 | -17.12% | $149,003,957 |
| Spyre Therapeutics Inc | SYRE | Healthcare | 28.78% | 1,464,169 | -443,158 | -23.23% | $129,988,924 |
| Apogee Therapeutics Inc | APGE | Healthcare | 17.24% | 586,691 | +3,100 | +0.53% | $77,871,496 |
| Jade Biosciences Inc | JBIO | Other | 7.76% | 1,577,750 | - | - | $35,057,605 |
Showing 4 of 4 holdings in the latest reporting period.